LIC MF Healthcare Fund
The fund maintains a concentrated bet on India's pharmaceutical and healthcare ecosystem, with nearly 70% in pharma companies and roughly 23% in hospital operators. The portfolio's stability month-on-month suggests the manager is confident in current valuations and competitive positions of large-cap drugmakers like Sun Pharma and mid-tier players such as Neuland. With over half the portfolio in just ten holdings and only modest cash, this is a high-conviction, low-diversification play suited for investors betting on domestic pharma's export strength and healthcare services growth.
Portfolio analysis · April 2026
NAV & Returns
| Plan | NAV | 1M | 3M | 6M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|---|---|
| Direct Growth | ₹33.6500 | — | — | — | — | — | — |
| Regular Growth | ₹30.5007 | +9.61% | +9.05% | +1.38% | +8.88% | — | — |
| Direct IDCW | ₹33.6396 | — | — | — | — | — | — |
| Regular IDCW | ₹30.5012 | — | — | — | — | — | — |
Portfolio Metrics(latest month)
What Changed2026-03-31 → 2026-04-30
| Stock | Weight | |
|---|---|---|
| No new entries this month | ||
Full Holdings
| # | Holding | % to NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Ltd. INE044A01036 | 11.22% |
| 2 | Apollo Hospitals Enterprise Ltd. INE437A01024 | 6.52% |
| 3 | Torrent Pharmaceuticals Ltd. INE685A01028 | 6.50% |
| 4 | Aurobindo Pharma Ltd. INE406A01037 | 5.15% |
| 5 | Divi's Laboratories Ltd. INE361B01024 | 4.74% |
| 6 | Fortis Healthcare Ltd. INE061F01013 | 4.70% |
| 7 | Neuland Laboratories Ltd. INE794A01010 | 4.59% |
| 8 | Onesource Specialty Pharma Ltd. INE013P01021 | 4.56% |
| 9 | Piramal Pharma Ltd. INE0DK501011 | 4.33% |
| 10 | Treps | 4.17% |
| 11 | Glenmark Pharmaceuticals Ltd. INE935A01035 | 3.41% |
| 12 | Navin Fluorine International Ltd. INE048G01026 | 3.32% |
| 13 | Alkem Laboratories Ltd. INE540L01014 | 3.20% |
| 14 | Cipla Ltd. INE059A01026 | 3.03% |
| 15 | IPCA Laboratories Ltd. INE571A01038 | 3.01% |
| 16 | Abbott India Ltd. INE358A01014 | 2.91% |
| 17 | Gland Pharma Ltd. INE068V01023 | 2.91% |
| 18 | Concord Biotech Ltd. INE338H01029 | 2.77% |
| 19 | Artemis Medicare Services Ltd. INE025R01021 | 2.70% |
| 20 | Metropolis Healthcare Ltd. INE112L01020 | 2.67% |
Sector Allocation
Top 10 sectors by % to NAV. Excludes derivatives.